Education
About Us
Working with TipRanks
Follow Us
Andrew John Sneddon Insider Profile
4 Followers
Andrew John Sneddon, Director at Amplia Therapeutics, holds 364.89K shares in Amplia Therapeutics (Ticker: INNMF). Most recently, Andrew John Sneddon Sold 611,111 shares of Amplia Therapeutics on Aug 08, 2017 for an estimated value of $27.50K.
Andrew John Sneddon Amplia Therapeutics (INNMF)Director
Amplia Therapeutics (INNMF)
Director
Ranked #4,755 out of 106,487 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+86.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew John Sneddon's holdings
Insider Roles
Director
Roles that Andrew John Sneddon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 09, 2016 - Mar 09, 2017
Return:+331.20%
The most profitable trade made by Andrew John Sneddon
Andrew John Sneddon's Trading History
List of latest transactions for each holding click on a transaction to see Andrew John Sneddon's performance on stock
You May Also Like
Andrew John Sneddon insider profile FAQ
What is the percentage of profitable transactions made by Andrew John Sneddon?
The percentage of profitable transactions made by Andrew John Sneddon is 60%.
What is the average return per transaction made by Andrew John Sneddon?
The average return per transaction made by Andrew John Sneddon is 86.50%.
What stocks does Andrew John Sneddon hold?
Andrew John Sneddon holds: INNMF stocks.
What was Andrew John Sneddon’s latest transaction?
Andrew John Sneddon latest transaction was an Informative Sell of $27.50K.
What was Andrew John Sneddon's most profitable transaction?
Andrew John Sneddon’s most profitable transaction was an Informative Buy of INNMF stock on March 9, 2016. The return on the trade was 331.20%.
What is Andrew John Sneddon's role in Amplia Therapeutics?
Andrew John Sneddon's role in Amplia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.